Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

CHMX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

CHMX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

NEXT-ChemX Corporation.(CHMX US)

$0.01+0.000.00%Ext:$0.01+0.000.00%(Market Closed · 21:00:00 UTC)
Ask AI
ProfileEntity StructureAll DocumentsFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

NEXT-ChemX Corporation.(CHMX US)

$0.01+0.000.00%Ext:$0.01+0.000.00%(Market Closed · 21:00:00 UTC)
Ask AI
ProfileEntity StructureAll DocumentsFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
All Documents

Financials & Metrics

FinancialsChartingShort InterestEmployees
All Documents

Financials & Metrics

FinancialsChartingShort InterestEmployees

NEXT-ChemX Corporation. — Company Profile

NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.

Sector
Technology
Industry
Software - Application
Exchange
UU
CEO
Dale Pfost
Headquarters
Las Vegas, TX, US
IPO Date
Sep 26, 2019
Employees
5
Website
www.next-chemx.com

Key Metrics

Price
$0.01
Market Cap
$285.47K
Revenue (TTM)
$0.00
Net Income (TTM)
$-455639.00
EPS (TTM)
-0.02
P/E (TTM)
-0.15
P/B (TTM)
-0.07
Dividend Yield
0.00%
ROE (TTM)
11.92%
ROA (TTM)
-14.37%
Operating Margin
0.00%
Beta
-174.05

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.

Website
www.next-chemx.com
Location
Las Vegas, TX, US
Phone512 663 2690
Employees5
CEODale Pfost
SectorTechnology
IndustrySoftware - Application
IPO DateSep 26, 2019

Latest Documents

SEC Filings(139)

Expand
  • 10-K/AFY 2024ended 31 Dec 20242 Sep
  • 8-KEntry into a Material Definitive Agreement22 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers8 May
  • 8-KOther Events20 Apr
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers20 Jan
  • 10-Q/AQ3ended 30 Sept 202418 Nov 2025
  • 8-KOther Events3 Nov 2025
  • Form 4Statement of changes in beneficial ownership2 Oct 2025
  • Form 4JOHNSON JOHN MICHAEL2 Oct 2025
  • Form 4/AStatement of changes in beneficial ownership (amendment)1 Oct 2025
  • Form 4/AJOHNSON JOHN MICHAEL1 Oct 2025
  • 10-Q/AQ2ended 30 Jun 202416 Sep 2025
  • 10-QQ2ended 30 Jun 202519 Aug 2025
  • NT 10-QQ2ended 30 Jun 202515 Aug 2025
  • 10-QQ1ended 31 Mar 202519 May 2025
  • NT 10-QQ1ended 31 Mar 202515 May 2025
  • 10-KFY 2024ended 31 Dec 202430 Apr 2025
  • 10-K/AFY 2023ended 31 Dec 202328 Apr 2025
  • NT 10-KFY 2024ended 31 Dec 20241 Apr 2025
  • 10-QQ3ended 30 Sept 202419 Nov 2024

Key Stats

Trading

Px/Chg 1D$0.01 / +0.00%
Avg Volume262.72
Beta-174.05
Mkt Cap285.47K
FD Mkt Cap39.97K

Float

Shrs Out/Float28.55M / 12.68M
Short Float0.00%
Days to Cover999.99
Stock Repurchased$0.00

Current Valuation

EV3.19M
EV/EBITDA-2.28
EV/Sales0.00
P/B-0.07
P/S0.00
FCF Yield-115.66%
ROE11.92%
ROA-14.37%
Current Ratio0.14

Estimates

P/E-0.15
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgMay '22May '23Jul '24May '25Oct '26
PRICE-BASED RATIOS
Price / Earnings-85.02-150.85-167.39-28.33-77.90-0.63
Price / Sales0.000.000.000.000.000.00
Price / Book Value-185.13157.15398.87-1,432.92-48.69-0.07
Price / Free Cash Flow-222.90-369.87-311.66-339.95-92.18-0.86
ENTERPRISE VALUE METRICS
Enterprise Value155.4269.8292.867.7143.73.2
Enterprise Value / Sales0.000.000.000.000.000.00
Enterprise Value / EBITDA-99.26-190.80-175.55-29.83-90.93-9.20
Enterprise Value / EBIT-89.34-152.69-175.03-27.92-82.81-8.27

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '20Dec '21Dec '22Dec '23Dec '24
INCOME STATEMENT
Revenue—-----
Gross Income—--0.4-0.0-0.0-0.2
EBITDA—0.0-1.4-1.7-2.3-1.6
EBIT95.8%-0.1-1.8-1.7-2.4-1.7
Net Income—0.3-1.8-1.7-2.4-1.8
EPS (Diluted)—0.04-0.08-0.07-0.08-0.06
BALANCE SHEET
Cash & ST Inv22.7%0.00.00.00.10.1
Total Assets188.8%0.03.23.23.33.3
Total Liabilities135.2%0.21.52.53.96.2
Total Shareholder Equity108.2%-0.21.70.7-1.1-2.9
CASH FLOW
Net Operating Cash Flow—0.2-0.7-0.9-0.5-1.5
Cap Ex—--0.0-0.0--
Free Cash Flow—0.2-0.7-0.9-0.5-1.5

Enterprise Value Bridge

Millions USD18 Nov '26
Price (As of 18 Nov '26)0.01
Basic Shares28.55
Market Cap0.3
Diluted Shares28.55
Fully Diluted Shares Outstanding28.55
Fully Diluted Market Cap0.3
+Consolidated Debt2.9
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-0.0
−Short-term Investments-0.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value3.2

Related companies

Element Solutions Inc

ESI US

Cabot Corp

CBT US

Wd 40 Co

WDFC US

Flotek Industries Inc/cn/

FTK US

ASP Isotopes Inc.

ASPI US

Orion S.A.

OEC US

Arq, Inc.

ARQ US

PV Nano Cell, Ltd.

PVNNF US

Versum Materials, Inc.

VSM XS

NEXT-ChemX Corporation. — Company Profile

NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.

Sector
Technology
Industry
Software - Application
Exchange
UU
CEO
Dale Pfost
Headquarters
Las Vegas, TX, US
IPO Date
Sep 26, 2019
Employees
5
Website
www.next-chemx.com

Key Metrics

Price
$0.01
Market Cap
$285.47K
Revenue (TTM)
$0.00
Net Income (TTM)
$-455639.00
EPS (TTM)
-0.02
P/E (TTM)
-0.15
P/B (TTM)
-0.07
Dividend Yield
0.00%
ROE (TTM)
11.92%
ROA (TTM)
-14.37%
Operating Margin
0.00%
Beta
-174.05

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.

Website
www.next-chemx.com
Location
Las Vegas, TX, US
Phone512 663 2690
Employees5
CEODale Pfost
SectorTechnology
IndustrySoftware - Application
IPO DateSep 26, 2019

Latest Documents

SEC Filings(139)

Expand
  • 10-K/AFY 2024ended 31 Dec 20242 Sep
  • 8-KEntry into a Material Definitive Agreement22 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers8 May
  • 8-KOther Events20 Apr
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers20 Jan
  • 10-Q/AQ3ended 30 Sept 202418 Nov 2025
  • 8-KOther Events3 Nov 2025
  • Form 4Statement of changes in beneficial ownership2 Oct 2025
  • Form 4JOHNSON JOHN MICHAEL2 Oct 2025
  • Form 4/AStatement of changes in beneficial ownership (amendment)1 Oct 2025
  • Form 4/AJOHNSON JOHN MICHAEL1 Oct 2025
  • 10-Q/AQ2ended 30 Jun 202416 Sep 2025
  • 10-QQ2ended 30 Jun 202519 Aug 2025
  • NT 10-QQ2ended 30 Jun 202515 Aug 2025
  • 10-QQ1ended 31 Mar 202519 May 2025
  • NT 10-QQ1ended 31 Mar 202515 May 2025
  • 10-KFY 2024ended 31 Dec 202430 Apr 2025
  • 10-K/AFY 2023ended 31 Dec 202328 Apr 2025
  • NT 10-KFY 2024ended 31 Dec 20241 Apr 2025
  • 10-QQ3ended 30 Sept 202419 Nov 2024

Key Stats

Trading

Px/Chg 1D$0.01 / +0.00%
Avg Volume262.72
Beta-174.05
Mkt Cap285.47K
FD Mkt Cap39.97K

Float

Shrs Out/Float28.55M / 12.68M
Short Float0.00%
Days to Cover999.99
Stock Repurchased$0.00

Current Valuation

EV3.19M
EV/EBITDA-2.28
EV/Sales0.00
P/B-0.07
P/S0.00
FCF Yield-115.66%
ROE11.92%
ROA-14.37%
Current Ratio0.14

Estimates

P/E-0.15
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgMay '22May '23Jul '24May '25Oct '26
PRICE-BASED RATIOS
Price / Earnings-85.02-150.85-167.39-28.33-77.90-0.63
Price / Sales0.000.000.000.000.000.00
Price / Book Value-185.13157.15398.87-1,432.92-48.69-0.07
Price / Free Cash Flow-222.90-369.87-311.66-339.95-92.18-0.86
ENTERPRISE VALUE METRICS
Enterprise Value155.4269.8292.867.7143.73.2
Enterprise Value / Sales0.000.000.000.000.000.00
Enterprise Value / EBITDA-99.26-190.80-175.55-29.83-90.93-9.20
Enterprise Value / EBIT-89.34-152.69-175.03-27.92-82.81-8.27

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '20Dec '21Dec '22Dec '23Dec '24
INCOME STATEMENT
Revenue—-----
Gross Income—--0.4-0.0-0.0-0.2
EBITDA—0.0-1.4-1.7-2.3-1.6
EBIT95.8%-0.1-1.8-1.7-2.4-1.7
Net Income—0.3-1.8-1.7-2.4-1.8
EPS (Diluted)—0.04-0.08-0.07-0.08-0.06
BALANCE SHEET
Cash & ST Inv22.7%0.00.00.00.10.1
Total Assets188.8%0.03.23.23.33.3
Total Liabilities135.2%0.21.52.53.96.2
Total Shareholder Equity108.2%-0.21.70.7-1.1-2.9
CASH FLOW
Net Operating Cash Flow—0.2-0.7-0.9-0.5-1.5
Cap Ex—--0.0-0.0--
Free Cash Flow—0.2-0.7-0.9-0.5-1.5

Enterprise Value Bridge

Millions USD18 Nov '26
Price (As of 18 Nov '26)0.01
Basic Shares28.55
Market Cap0.3
Diluted Shares28.55
Fully Diluted Shares Outstanding28.55
Fully Diluted Market Cap0.3
+Consolidated Debt2.9
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-0.0
−Short-term Investments-0.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value3.2

Related companies

Element Solutions Inc

ESI US

Cabot Corp

CBT US

Wd 40 Co

WDFC US

Flotek Industries Inc/cn/

FTK US

ASP Isotopes Inc.

ASPI US

Orion S.A.

OEC US

Arq, Inc.

ARQ US

PV Nano Cell, Ltd.

PVNNF US

Versum Materials, Inc.

VSM XS